A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
PHASE2Not yet recruitingINTERVENTIONAL
Enrollment
36
Participants
Timeline
Start Date
October 24, 2025
Primary Completion Date
January 8, 2029
Study Completion Date
January 8, 2029
Conditions
Pulmonary Hypertension
Interventions
DRUG
PF-07868489
Participants will receive subcutaneous doses of PF-07868489 every 4 weeks